Last reviewed · How we verify

NCT07326982

Ultrasound-Guided Interfascial Hydrodissection for Gluteal Myofascial Pain in Piriformis Syndrome: A Prospective Study

Not yet recruiting NA Last updated 13 March 2026
What this trial tests

NA trial testing Ultrasound-Guided Interfascial Hydrodissection in Piriformis Syndrome in 42 participants. Not yet recruiting.

Timeline
26 March 2026
Primary endpoint
28 June 2026
28 September 2026

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment42
Start date26 March 2026
Primary completion28 June 2026
Estimated completion28 September 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 75, any sex, with Piriformis Syndrome or Gluteus Maximus Myofascial Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, double-blind prospective trial investigates whether ultrasound-guided interfascial hydrodissection using 10% dextrose is more effective than dry needling in treating gluteal myofascial pain coexisting with piriformis syndrome. Following diagnostic piriformis injection response, eligible patients will be randomized into two treatment arms and followed at 1 hour, 1 week, 1 month, and 3 months. The primary hypothesis is that interfascial hydrodissection will provide superior long-term analgesic outcomes due to fascial separation, neuromodulation, and nociceptor suppression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Piriformis Syndrome

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07326982.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing